FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

The Food and Drug Administration (FDA) authorized Novavax’s COVID vaccine for adults on Wednesday, offering a protein-based alternative to mRNA shots from other pharmaceutical companies.

The newly authorized vaccine is scheduled in two doses separated by 21 days.

READ MORE
 

FDA Authorizes Novavax COVID Vaccine

‘Many’ Inside Saudi Arabia Want Normalization

According to former US secretary of state, Mike Pompeo,…
Read more

IoT Devices Put Your Security at Risk

There appears to be a growing problem of security threat…
Read more

Petition for EU to Ban Biometric Surveillance

A coalition consisting of both civil and digital rights groups…
Read more